Kepler Capital Remains a Buy on British American Tobacco (BATS)
In a report released on May 18, Emanuele Sartori from Kepler Capital maintained a Buy rating on British American Tobacco, with a price target of p5,500.00. The company’s shares closed yesterday at p4,926.00.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
According to TipRanks, Sartori is ranked #8595 out of 12185 analysts.
In addition to Kepler Capital , British American Tobacco also received a Buy from Citi’s Simon Hales in a report issued on May 14. However, on May 15, Goldman Sachs assigned a Hold rating to British American Tobacco (LSE: BATS).
Based on British American Tobacco’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of p13.54 billion and a net profit of p3.25 billion. In comparison, last year the company earned a revenue of p13.53 billion and had a GAAP net loss of p1.45 billion
Based on the recent corporate insider activity of 70 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of BATS in relation to earlier this year.
Read More on GB:BATS:
Disclaimer & DisclosureReport an Issue
- BAT Discloses Share Sale by Chief Corporate Officer Kingsley Wheaton
- British American Tobacco Cancels New Tranche of Shares in Ongoing Buyback
- British American Tobacco price target raised to 5,200 GBp at Citi
- Analyst Reiterates Buy as U.S. Growth, Margin Upside and Lower Regulatory Risk Drive DCF-Based Price Target Increase to 5,300p
- BAT discloses off‑market share transfer by interim CFO Javed Iqbal
